Impax Shareholders

     SAN FRANCISCO – A federal judge dismissed with leave to amend a shareholders derivative complaint accusing Impax Laboratories of propping up its stock price with false and misleading statements.
     U.S. District Judge Haywood Gilliam Jr. on Sept. 3 gave the plaintiffs 21 days to amend but “cautions plaintiffs that it will consider only factual, rather than conclusory, allegations when assessing the viability of any amended complaint.”

%d bloggers like this: